New cases tested for RR-/MDR-TB (%) in Poland
Poland: New cases tested for RR-/MDR-TB was 85.0% in 2024. ▲ Rising
New cases tested for RR-/MDR-TB in Poland, 2005–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Poland recorded 85.0% for new cases tested for rr-/mdr-tb in 2024.
The figure is down 1.2% on the previous year and down 10.5% over ten years.
Over the whole period, new cases tested for rr-/mdr-tb in Poland peaked at 100.0% in 2005 and was at its lowest, 60.0%, in 2007.
Poland ranks 118th of 192 countries on this measure, in the middle of the range.
The long-run direction has been consistently rising across the 19 years of available data.
New cases tested for RR-/MDR-TB in Poland, year by year
| Year | Value | Change |
|---|---|---|
| 2005 | 100.0% | — |
| 2007 | 60.0% | -40.0% |
| 2008 | 89.0% | +48.3% |
| 2009 | 76.0% | -14.6% |
| 2010 | 77.0% | +1.3% |
| 2011 | 88.0% | +14.3% |
| 2012 | 91.0% | +3.4% |
| 2013 | 93.0% | +2.2% |
| 2014 | 95.0% | +2.2% |
| 2015 | 92.0% | -3.2% |
| 2016 | 92.0% | +0.0% |
| 2017 | 93.0% | +1.1% |
| 2018 | 90.0% | -3.2% |
| 2019 | 90.0% | +0.0% |
| 2020 | 90.0% | +0.0% |
| 2021 | 92.0% | +2.2% |
| 2022 | 88.0% | -4.3% |
| 2023 | 86.0% | -2.3% |
| 2024 | 85.0% | -1.2% |
Poland compared with similar countries
- Poland's 85.0% is below the median for high income countries, which is 91.0%, 93% of the median. (64 countries reporting)
- Poland's 85.0% is below the median for Europe & Central Asia, which is 91.0%, 93% of the median. (49 countries reporting)
Biggest year-on-year movements
Years where New cases tested for RR-/MDR-TB in Poland changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2008 | +48.3% | 60.0% | 89.0% |
| 2007 | -40.0% | 100.0% | 60.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 81.2% | 60.0% | 100.0% | 4 |
| 2010s | 90.1% | 77.0% | 95.0% | 10 |
| 2020s | 88.2% | 85.0% | 92.0% | 5 |
Countries ranked near Poland
More health data for Poland
- Un projection of annual infant deaths, annual growth rate -1.23 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9071 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,693 deaths per 1,000 people (2090)
- Number of infants who die before age 1 80 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -5.59 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0201 units per person (2025)
- Population ages 00-04, male, annual growth rate -5.49 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is new cases tested for rr-/mdr-tb in Poland?
- New cases tested for rr-/mdr-tb in Poland was 85.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest new cases tested for rr-/mdr-tb recorded in Poland?
- The highest recorded value was 100.0% in 2005.
- What is the lowest new cases tested for rr-/mdr-tb recorded in Poland?
- The lowest recorded value was 60.0% in 2007.
- How does Poland rank for new cases tested for rr-/mdr-tb?
- Poland ranks 118th out of 192 countries with data for 2024.
- Is new cases tested for rr-/mdr-tb rising or falling in Poland?
- Over the last ten years it is down 10.5%. The long-run trend across the full record is rising.
- Where does this Poland data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of New cases tested for RR-/MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 19 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).